In the last few years, GALNT2 has attracted great attention as a possible player in many human metabolic abnormalities that all share the common ground of insulin resistance, including atherogenic dyslipidemia [8,9,10,11,12,13,14], type 2 diabetes [15,16] and obesity [17,18]. The gene discussed is GALNT2; the disease is Obesity.